OverviewSuggest Edit

Penumbra designs, develops, manufactures, and markets medical devices. The Company offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies, aspiration based thrombectomy systems and accessory devices, and revascularization device for mechanical thrombectomy. It also provides neurovascular embolization coiling systems and neurovascular stents. In addition, the Company offers neurosurgical aspiration tools and detachable embolic coil systems and microcatheter devices.

TypePublic
Founded2004
HQAlameda, US
Websitepenumbrainc.com
Employee Ratings3.6

Latest Updates

Employees (est.) (Dec 2019)2,700(+23%)
Job Openings4
Revenue (FY, 2019)$547.4 M(+24%)
Share Price (May 2020)$177

Key People/Management at Penumbra

Arani Bose

Arani Bose

Chief Innovator and Director
Don Kassing

Don Kassing

Director
Harpreet Grewal

Harpreet Grewal

Director
Thomas C. Wilder

Thomas C. Wilder

Director
Janet Leeds

Janet Leeds

Director
Surbhi Sarna

Surbhi Sarna

Director
Show more

Penumbra Office Locations

Penumbra has offices in Alameda, Atlanta, Chicago, Melbourne and in 3 other locations
Alameda, US (HQ)
1321 Harbor Bay Pkwy
Alameda, US
1351 Harbor Bay Pkwy
Atlanta, US
Atlanta, GA, USA
Chicago, US
Chicago, IL, USA
Melbourne, US
Melbourne, FL, USA
Darlinghurst, AU
Suite 3, Level 5, 1 Oxford Street
Show all (10)

Penumbra Financials and Metrics

Penumbra Revenue

Embed Graph
View revenue for all periods
Penumbra's revenue was reported to be $547.41 m in FY, 2019
USD

Revenue (Q1, 2020)

137.3m

Gross profit (Q1, 2020)

88.0m

Gross profit margin (Q1, 2020), %

64.1%

Net income (Q1, 2020)

888.0k

EBIT (Q1, 2020)

610.0k

Market capitalization (22-May-2020)

6.2b

Closing stock price (22-May-2020)

177.0

Cash (31-Mar-2020)

72.5m

EV

6.2b
Penumbra's current market capitalization is $6.2 b.
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

186.1m263.3m333.8m444.9m547.4m

Revenue growth, %

41%

Cost of goods sold

62.0m92.5m116.6m152.4m175.4m

Gross profit

124.1m170.8m217.1m292.5m372.0m
Quarterly
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Revenue

50.4m57.9m65.1m67.2m73.2m80.6m83.9m102.7m109.6m111.8m128.4m134.2m139.5m137.3m

Cost of goods sold

16.9m18.0m23.6m24.3m25.5m29.7m29.1m36.1m37.4m36.8m44.5m40.3m43.5m49.3m

Gross profit

33.5m39.9m41.5m42.9m47.7m50.9m54.8m66.6m72.3m75.0m83.9m93.9m96.0m88.0m

Gross profit Margin, %

66%69%64%64%65%63%65%65%66%67%65%70%69%64%
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

19.5m13.2m50.6m67.9m72.8m

Accounts Receivable

57.2m47.7m58.0m81.9m105.9m

Prepaid Expenses

14.7m12.2m14.9m

Inventories

56.8m73.0m94.9m115.7m153.0m
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

2.4m14.8m4.7m2.9m47.0m

Depreciation and Amortization

1.8m2.3m3.8m6.2m8.1m

Inventories

(25.1m)(19.7m)(18.8m)(22.3m)(41.4m)

Accounts Payable

132.0k1.4m1.9m1.3m6.0m
USDY, 2020

EV/EBIT

10.2 k x

EV/CFO

-1 k x

Financial Leverage

1.4 x
Show all financial metrics

Penumbra Online and Social Media Presence

Embed Graph

Penumbra Company Culture

  • CEO Rating

    A+

    90/100

Learn more on Comparably

Penumbra News and Updates

Penumbra, Inc. to Present at the 38th Annual J.P. Morgan Healthcare Conference

ALAMEDA, Calif., Dec. 31, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 14, 2020. Event: 38th Annual J.P. Morgan Healthcare...

Sri Kosaraju Promoted to President and CFO of Penumbra

ALAMEDA, Calif., Aug. 29, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced the promotion of Sri Kosaraju to President, in addition to his current responsibilities as CFO of Penumbra. Kosaraju joined Penumbra as...

Penumbra, Inc. to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

ALAMEDA, Calif., Aug. 27, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Morgan Stanley 17th Annual Global Healthcare Conference in New York, NY on Tuesday, September 10, 2019. Event: Morgan Stanley 17th Annual...

Penumbra, Inc. Reports First Quarter 2019 Financial Results

ALAMEDA, Calif., May 7, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended March 31, 2019. Revenue of $128.4 million in the first quarter of 2019, an increase of 25.1%,...

Global Aneurysm Coiling and Embolization Devices Markets 2019-2023 - Key Vendors are Acandis, Johnson & Johnson Services, Medtronic, Penumbra, Stryker, & Terumo

DUBLIN, April 30, 2019 /PRNewswire/ -- The "Global Aneurysm Coiling and Embolization Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The aneurysm coiling and embolization devices market will register a CAGR of over 10% by 2023. Technological advances...

Global Intracranial Stents Market to 2026 with Boston Scientific, Johnson & Johnson Services, Stryker, Penumbra, Medtronic, Terumo, and Cook Medical Dominating

DUBLIN, April 24, 2019 /PRNewswire/ -- The "Global Intracranial Stents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering. The global...
Show more

Penumbra Frequently Asked Questions

  • When was Penumbra founded?

    Penumbra was founded in 2004.

  • Who are Penumbra key executives?

    Penumbra's key executives are Arani Bose, Don Kassing and Harpreet Grewal.

  • How many employees does Penumbra have?

    Penumbra has 2,700 employees.

  • What is Penumbra revenue?

    Latest Penumbra annual revenue is $547.4 m.

  • What is Penumbra revenue per employee?

    Latest Penumbra revenue per employee is $202.7 k.

  • Who are Penumbra competitors?

    Competitors of Penumbra include Stryker, Acelity and Mevion Medical Systems.

  • Where is Penumbra headquarters?

    Penumbra headquarters is located at 1321 Harbor Bay Pkwy, Alameda.

  • Where are Penumbra offices?

    Penumbra has offices in Alameda, Atlanta, Chicago, Melbourne and in 3 other locations.

  • How many offices does Penumbra have?

    Penumbra has 10 offices.